KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemed (CHE) EBIT (2016 - 2025)

Historic EBIT for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $74.8 million.

  • Chemed's EBIT fell 1888.84% to $74.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $351.5 million, marking a year-over-year decrease of 344.47%. This contributed to the annual value of $366.5 million for FY2024, which is 761.2% up from last year.
  • Per Chemed's latest filing, its EBIT stood at $74.8 million for Q3 2025, which was down 1888.84% from $68.1 million recorded in Q2 2025.
  • In the past 5 years, Chemed's EBIT registered a high of $113.9 million during Q4 2024, and its lowest value of $68.1 million during Q2 2025.
  • For the 5-year period, Chemed's EBIT averaged around $85.9 million, with its median value being $86.8 million (2023).
  • Per our database at Business Quant, Chemed's EBIT crashed by 3156.74% in 2021 and then soared by 3697.05% in 2023.
  • Quarter analysis of 5 years shows Chemed's EBIT stood at $98.0 million in 2021, then decreased by 17.04% to $81.3 million in 2022, then skyrocketed by 36.97% to $111.4 million in 2023, then increased by 2.23% to $113.9 million in 2024, then plummeted by 34.36% to $74.8 million in 2025.
  • Its EBIT was $74.8 million in Q3 2025, compared to $68.1 million in Q2 2025 and $94.8 million in Q1 2025.